blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3165540

EP3165540 - ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  26.02.2021
Database last updated on 02.11.2024
FormerExamination is in progress
Status updated on  19.10.2018
FormerRequest for examination was made
Status updated on  10.11.2017
FormerThe application has been published
Status updated on  07.04.2017
Most recent event   Tooltip26.02.2021Refusal of applicationpublished on 31.03.2021  [2021/13]
Applicant(s)For all designated states
Celldex Therapeutics, Inc.
119 Fourth Avenue
Needham, MA 02494-2725 / US
[2017/19]
Inventor(s)01 / KELER, Tibor
198 Cafferty Rd
Pipersville, PA 18947-1613 / US
02 / MARSH, Henry C.
297 Summer Avenue
Reading, MA 01867 / US
03 / HE, Lizhen
1675 Ridgeview Drive
Allentown, PA 18104 / US
04 / VITALE, Laura A.
5574 Bittersweet Lane
Doylestown, PA 18902 / US
05 / THOMAS, Lawrence J.
1 Fox Ridge Road
Easton, MA 02375 / US
 [2017/19]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2017/19]Tuxworth, Pamela M.
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date16193133.213.04.2011
[2017/19]
Priority number, dateUS20100323720P13.04.2010         Original published format: US 323720 P
US201161471459P04.04.2011         Original published format: US 201161471459 P
[2017/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3165540
Date:10.05.2017
Language:EN
[2017/19]
Search report(s)(Supplementary) European search report - dispatched on:EP24.01.2017
ClassificationIPC:C07K16/28, A61K39/395, A61P35/00, A61P37/02, C07K14/705, A01K67/027
[2017/19]
CPC:
C07K16/2878 (EP,CN,US); A61K38/17 (KR); A61K38/18 (KR);
A61K39/395 (KR); A61K47/42 (KR); A61K48/00 (KR);
A61K49/16 (KR); A61P1/04 (EP); A61P1/16 (EP);
A61P13/12 (EP); A61P15/08 (EP); A61P17/00 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P19/04 (EP);
A61P21/00 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61P31/12 (EP); A61P33/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/02 (EP); A61P37/04 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/14 (EP); A61P5/40 (EP); A61P7/04 (EP);
A61P7/06 (EP); A61P9/10 (EP); C07K14/435 (KR);
C07K14/475 (KR); C07K16/18 (KR); C07K16/28 (KR);
A61K2039/505 (EP,US); C07K2317/565 (US); C07K2317/732 (EP,US);
C07K2317/734 (EP,US); C07K2317/74 (EP,US); C07K2317/75 (US);
C07K2317/92 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/50]
Former [2017/19]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA07.11.2017
ME07.11.2017
TitleGerman:ANTIKÖRPER ZUR BINDUNG VON HUMANEM CD27 UND VERWENDUNGEN DAVON[2017/19]
English:ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF[2017/19]
French:ANTICORPS LIANT UN CD27 HUMAIN ET LEURS UTILISATIONS[2017/19]
Examination procedure10.10.2016Date on which the examining division has become responsible
07.11.2017Examination requested  [2017/50]
28.02.2018Amendment by applicant (claims and/or description)
23.10.2018Despatch of a communication from the examining division (Time limit: M06)
29.05.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
02.08.2019Reply to a communication from the examining division
05.11.2020Cancellation of oral proceeding that was planned for 25.11.2020
16.11.2020Despatch of communication that the application is refused, reason: substantive examination [2021/13]
25.11.2020Date of oral proceedings (cancelled)
26.11.2020Application refused, date of legal effect [2021/13]
Parent application(s)   TooltipEP11730118.4  / EP2558498
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
02.08.2019Request for further processing filed
02.08.2019Full payment received (date of receipt of payment)
Request granted
14.08.2019Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
28.02.2018Request for further processing filed
28.02.2018Full payment received (date of receipt of payment)
Request granted
13.03.2018Decision despatched
Fees paidRenewal fee
10.10.2016Renewal fee patent year 03
10.10.2016Renewal fee patent year 04
10.10.2016Renewal fee patent year 05
10.10.2016Renewal fee patent year 06
27.04.2017Renewal fee patent year 07
27.04.2018Renewal fee patent year 08
29.04.2019Renewal fee patent year 09
27.04.2020Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO2008051424  (UNIV SOUTHAMPTON [GB], et al);
 [X]EP2090320  (HELMHOLTZ INFEKTIONSFORSCHUNG [DE]);
by applicantUS6008200
 US4436727
 US4439196
 US4447233
 US4447224
 US4475196
 US4486194
 US4487603
 US4522811
 US4596556
 EP0198474
 WO8704462
 US4790824
 WO8901036
 EP0304578
 EP0318216
 US4866034
 EP0338841
 US4877611
 US4912094
 WO9006951
 US4941880
 EP0414374
 US5064413
 WO9203918
 WO9222645
 WO9222653
 WO9312227
 US5223409
 US5312335
 WO9425585
 US5374548
 US5383851
 US5399163
 US5399331
 US5403484
 US5416016
 US5427908
 WO9602555
 US5545806
 US5545807
 WO9626277
 WO9629412
 US5569825
 US5571698
 US5580717
 US5620886
 US5625126
 US5633425
 US5661016
 WO9741731
 WO9824884
 US5770429
 US5789650
 US5804381
 US5814318
 US5840306
 US5843464
 US5854203
 US5856462
 WO9903884
 US5874299
 US5877397
 US5885793
 WO9933488
 US5969108
 WO9952549
 US6069233
 US6172197
 US6235525
 WO0172329
 WO02090986
 US6521404
 US6531127
 US6544731
 US6555313
 WO03040169
 US6582915
 US6593081
 US6774226
 US6911529
 WO2008051424
 WO2009061996
 WO1990US01348
 WO1999US05535
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.